{
  "Variants Include": [
    {
      "Gene": "RNF128",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.683G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "683"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "228"
          },
          "Description in input context": "E228K variant"
        },
        {
          "HGVS": "NM_001126112.3:c.683G>C",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "C",
            "position": "683"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "Q",
            "position": "228"
          },
          "Description in input context": "E228Q variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Cancer (generalized, based on p53 involvement)",
    "MONDO": "MONDO:0005171"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro ubiquitination assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells overexpressing RNF128 variants",
        "Description": "HEK293 cells were transfected with plasmids encoding wild-type or mutant RNF128 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.683G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "The E228K variant showed reduced ubiquitination activity of p53 compared to wild-type RNF128."
        },
        {
          "Variant": "NM_001126112.3:c.683G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "The E228Q variant exhibited significantly lower p53 ubiquitination activity than wild-type RNF128."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type RNF128 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Western blot and immunoblotting were used for quantification."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination activity ≥ 80% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination activity < 50% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell-based ubiquitination assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells",
        "Description": "HEK293 cells were transfected with wild-type or mutant RNF128 plasmids and analyzed for p53 ubiquitination."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.683G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "E228K variant showed reduced p53 ubiquitination in HEK293 cells compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.683G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "E228Q variant exhibited significantly lower p53 ubiquitination in HEK293 cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type RNF128 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Western blot and immunoblotting were used for quantification."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Ubiquitination activity ≥ 80% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Ubiquitination activity < 50% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}